Some Unique Considerations in Treatment of Multiple Sclerosis | Zendy

Faizan Mazhar | Zendy; Nafis Haider | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Some Unique Considerations in Treatment of Multiple Sclerosis

Author(s) -

Faizan Mazhar,

Nafis Haider

Publication year - 2016

Publication title -

asian journal of pharmaceutical research and health care

Language(s) - English

Resource type - Journals

eISSN - 2250-1444

pISSN - 2250-1460

DOI - 10.18311/ajprhc/2016/3909

Subject(s) - multiple sclerosis , medicine , osteoporosis , myelin sheath , population , pregnancy , intensive care medicine , myelin , immunology , environmental health , pathology , biology , central nervous system , genetics

Multiple Sclerosis (MS) is one of several diseases described as demyelinating because it causes damage to the myelin sheath. The presence of additional medical conditions like pregnancy, osteoporosis and infections are common with multiple sclerosis that adversely affects the health outcomes. The treatment of MS becomes more complex when compounded by these existing additional medical conditions. This review highlight important pharmacotherapeutic considerations in treatment of MS in these special patient population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research